Edition:
United States

Aptose Biosciences Inc (APTO.OQ)

APTO.OQ on NASDAQ Stock Exchange Capital Market

2.37USD
15 Oct 2018
Change (% chg)

$0.19 (+8.72%)
Prev Close
$2.18
Open
$2.15
Day's High
$2.50
Day's Low
$2.15
Volume
43,190
Avg. Vol
50,418
52-wk High
$4.55
52-wk Low
$1.30

Chart for

About

Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. Its product pipeline includes cancer drug candidates... (more)

Overall

Beta: 1.99
Market Cap(Mil.): $83.60
Shares Outstanding(Mil.): 34.66
Dividend: --
Yield (%): --

Financials

  APTO.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -0.76 -- --
ROI: -169.37 1.96 12.83
ROE: -169.37 1.12 14.95

BRIEF-Aptose Reports Q1 Loss Per Share $0.23

* APTOSE REPORTS RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2018

May 10 2018

BRIEF-Aptose Biosciences Says Exercises Early Option For Cg-806 License From Crystalgenomics

* APTOSE BIOSCIENCES INC - EXERCISES EARLY OPTION FOR CG-806 LICENSE FROM CRYSTALGENOMICS

May 07 2018

Earnings vs. Estimates